We evaluated the clinicopathologic, immunohistochemical, lectin histochemical, ultrastructural and morphometric characteristics of a series of 28 poorly differentiated carcinomas of the thyroid (PDCT). The 28 tumors were classified according to their predominant growth pattern as insular (n=12), trabecular (n=10) and solid subtypes (n=6). The overall mortality rate was 46%. No significant differences were found among the 3 subtypes. Data obtained by lectin histochemistry, electron microscopy, and morphometry point to a closer relationship of PDCT to follicular than to papillary carcinoma. Our results do not support the subdivision of PDCT into subtypes.
1. Hedinger CHR, Williams ED, Sobin LH. Histologic typing of thyroid tumors. World Health Organization international histological classification of tumors. Springer-Verlag, Berlin, 1988
2.
2. Rosai J, Carcangiu ML, De Lellis R. Tumors of the thyroid gland. Atlas of tumor pathology3rd series. Armed Forces Institute of Pathology, Washington, 1992
3.
3. LiVolsi V. Surgical Pathology of the Thyroid. WB Saunders, Philadelphia, 1990
4.
4. Franssila KC. Value of histologic classification of thyroid cancer. Acta Pathol Microbiol Scand [A] [Suppl.] 225:1-76, 1971
5.
5. Hedinger CHR, Sobin LH. Histological typing of thyroid tumors. World Health Organization international histological classification of tumors, Geneva, 1974
6.
6. Woolner LB, Beahrs OH, Black BM, McConaney WM, Keating FR Jr. Classification and prognosis of thyroid carcinoma: A study of 885 cases cases observed in a thirty-year period. Am J Surg102:354-388, 1961
7.
7. Tscholl-Ducommun J, Hedinger CHR. E. Papillary thyroid carcinoma. Morphology and prognosis. Virchows Arch [Pathol Anat]396:19-39, 1982
8.
8. Papotti M, Torchio B, Grassi L, Favero A, Bussolati G. Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid. Am J Surg Pathol20:686-694, 1996
9.
9. Cabanne F, Gerard-Marchant R, Heimann R, Williams ED. Turneurs malignes du corps thyroide. Prob1emes de diagnostic histopathologique. A propos de 692 lsions recueillies par le groupe cooperateur des Cancers du Corps Thyroide de 1'O.E.R.T.C.Ann Pathol19:129-148, 1974 (in French)
10.
10. Lucot H, David JF, Boneu A, Combes PF, Cabarrot E, Daly N. L'Epitheliome trabeculaire du corps thyroide. Une entit6 anatomo clinique a prognostic d6favorable?Bull Cancer Paris66:279-286, 1979 (in French)
11.
11. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer52:1849-1855, 1983
12.
12. Ljungberg O, Bondeson L, Bondeson A-G. Differentiated thyroid carcinoma, intermediate type: A new tumor entity with features of follicular and parafollicular cell carcinoma. Hum Pathol15:218-228, 1984
13.
13. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans' “wuchernde Struma.”Am J Surg Pathol8:655-658, 1984
14.
14. Fonseca E, Sobrinho-Simoes M. Diagnostic problems in differentiated carcinomas of the thyroid. Pathol Res Pract191:318-331, 1995
15.
15. Pilotti S, Collini P, Manzari A, Marubini E, Rilke F. Poorly differentiated forms of papillary thyroid carcinoma. Distinctive entities or morphological patterns?Semin Diagn Pathol12:249-249, 1995
16.
16. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol23:205-211, 1999
17.
17. Akslen LA, LiVolsi VA. Poorly differentiated thyroid carcinoma-it is important. Am J Surg Pathol24:310-312, 2000
18.
18. Massi D, Santucci M, Bianchi S, Vezzosi V, Zampi G. Ultrastructural features of solid/trabecular areas in differentiated thyroid carcinoma. Ultrastruct Pathol25:13-20, 2001
19.
19. Furihata M, Ohtsuki Y, Matsumoto M, Sonobe H, Okada Y, Watanabe R. Immunohistochemical characterization of a case of insular thyroid carcinoma. Pathology33:257-261, 2001
20.
20. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. P-catenin dysregulation in thyroid neoplasms. Down-regulation, aberrant nuclear expression, and CTNNB 1 exon 3 mutations are marked for aggressive tumor phenotypes and poor prognosis. Am J Pathol158:987-996, 2001
21.
21. Hsu S-M, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol75:734-738, 1981
22.
22. Johannessen JV. Use of paraffin material for electron microscopy. Pathol Annu12:189-224, 1977
23.
23. Johannessen JV, Sobrinho-Simoes MA, Finseth I. Ultrastructural morphometry of thyroid neoplasms. Am J Clin Pathol7:166-171, 1983
24.
24. Sobrinho-Simoes M, Damjanov I. Lectin histochemistry of papillary and follicular carcinoma of the thyroid gland. Arch Pathol Lab Med110:722-729, 1986
25.
25. Sobrinho-Simóes M, Sambade C, Nesland JM, Holm R, Damjanov I. Lectin histochemistry and ultrastructure of medullary carcinoma of the thyroid gland. Arch Pathol Lab Med114:369-375, 1990
26.
26. Ashfaq R, Vuitch F, Delgado R, Albores-Saavedra J. Papillary and follicular thyroid carcinomas with an insular component. Cancer73:416-423, 1994
27.
27. Papotti M, Botto Micca F, Favero A, Palestini N, Bussolati G. Poorly differentiated thyroid carcinomas with primordial cell component: A group of aggressive lesions sharing insular, trabecular and solid patterns. Am J Surg Pathol17:291-301, 1993
28.
28. Albores-Saavedra J, LiVolsi V, Williams E. Medullary carcinoma. Semin Diagn Pathol2:137-146, 1985
29.
29. Carcangiu M, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer55:805-828, 1985
30.
30. Franssila K, Ackerman L, Brown C, Hedinger C. Follicular carcinoma. Semin Diagn Pathol2:101-122, 1985
31.
31. Pilotti S, Collini P. DelBo R, Cattoretti G, Pierotti M, Rilke F. A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland. Am J Surg Pathol18:1054-1064, 1994
32.
32. Calmettes C, Caillou B, Moukhtar MS, Milhaud G, Gerard-Marchant R. Calcitonin and carcinoembryonic antigen in poorly differentiated follicular carcinoma. Cancer49:2342-2348, 1982
